About the Product

Description


Avityle Injection containing Avibactam is used in the management of resistant bacterial infections, mainly as part of combination antibiotic therapies. It helps enhance antibacterial effectiveness against beta-lactamase producing bacteria.

Avibactam works as a beta-lactamase inhibitor that protects partner antibiotics from bacterial enzyme degradation, thereby improving antibacterial activity against resistant organisms.

The injection is widely used in hospital and critical care settings for complicated bacterial infections and resistant infection management, leading to consistent institutional demand.

With increasing prevalence of multidrug-resistant bacterial infections and growing demand for advanced critical care therapies, this product offers strong business potential for retailers and distributors. Its resistance-targeting mechanism, broad clinical relevance, and steady market demand make it a reliable product for growth in the critical care anti-infective segment.

Some patients may experience nausea, vomiting, diarrhea, headache, injection site reactions, or rash. Rarely, severe allergic reactions, liver enzyme abnormalities, or antibiotic-associated colitis may occur and require immediate medical attention.

Avityle Injection is indicated for complicated intra-abdominal infections, complicated urinary tract infections, hospital-acquired infections, respiratory tract infections, and other serious bacterial infections when used in combination with appropriate antibiotics. It helps improve bacterial eradication and supports infection control in resistant cases.

This injection should be administered strictly under medical supervision by qualified healthcare professionals and only in combination with compatible antibiotics as prescribed. Use cautiously in patients with kidney disorders or beta-lactam allergy.

Store below 25°C, protected from moisture and direct sunlight. Keep the vial in its original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Avibactam 500mg Injection in the PCD pharma franchise market?

Avibactam 500mg Injection has high-end, specialized demand in the hospital, ICU, and critical-care anti-infective segment, making it a premium product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced injectable antibiotics.

Why should distributors include Avibactam Injection in their product range?

Distributors and agencies can benefit from hospital-based usage under strict specialist supervision. Avibactam is a β-lactamase inhibitor that helps restore the activity of certain antibiotics against resistant bacteria Commonly used in multi-drug resistant (MDR) bacterial infections, complicated urinary tract infections, intra-abdominal infections, and hospital-acquired infections (as part of combination therapy) Primarily used in ICUs, tertiary care hospitals, and infectious disease units Plays an important role in managing antibiotic-resistant organisms when used in combination regimens This strengthens a high-value critical-care and hospital anti-infective portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Avibactam Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from high-value institutional demand, hospital procurement contracts, low competition, and specialist-driven usage, along with reliable supply chain support and strong margin potential in the critical-care segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from professional marketing support, quality pharmaceutical products, and a dependable supply chain for advanced hospital business growth.